Daiwa Securities Group Inc. Inovio Pharmaceuticals, Inc. Transaction History

Daiwa Securities Group Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$0.39 - $0.94 $15,271 - $36,807	-39,157 Reduced 98.19%	720 $0
Q1 2023 May 02, 2023	BUY	$0.79 - $1.91 $6,075 - $14,689	7,691 Added 23.9%	39,877 $33,000
Q4 2022 Feb 06, 2023	SELL	$1.41 - $2.5 $11,402 - $20,217	-8,087 Reduced 20.08%	32,186 $50,000
Q3 2022 Nov 02, 2022	SELL	$1.66 - $2.79 $18,850 - $31,683	-11,356 Reduced 22.0%	40,273 $69,000
Q2 2022 Aug 09, 2022	BUY	$1.44 - $3.98 $44,199 - $122,162	30,694 Added 146.62%	51,629 $89,000
Q1 2022 Apr 29, 2022	BUY	$2.97 - $5.2 $18,844 - $32,994	6,345 Added 43.49%	20,935 $75,000
Q4 2021 Feb 03, 2022	BUY	$4.99 - $7.46 $34,934 - $52,227	7,001 Added 92.25%	14,590 $73,000
Q3 2021 Nov 05, 2021	BUY	$7.16 - $9.69 $51,408 - $69,574	7,180 Added 1755.5%	7,589 $54,000
Q1 2021 May 03, 2021	BUY	$8.81 - $16.96 $792 - $1,526	90 Added 28.21%	409 $4,000
Q4 2020 Feb 04, 2021	SELL	$8.5 - $12.85 $4,972 - $7,517	-585 Reduced 64.71%	319 $3,000
Q3 2020 Nov 02, 2020	BUY	$9.57 - $27.05 $3,253 - $9,197	340 Added 60.28%	904 $10,000
Q1 2020 May 14, 2020	BUY	$2.98 - $14.09 $193 - $915	65 Added 13.03%	564 $4,000
Q1 2018 May 02, 2018	BUY	$4.05 - $5.69 $2,020 - $2,839	499 New	499 $2,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $499M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.